Spelling suggestions: "subject:"arterial stiffness"" "subject:"marterial stiffness""
21 |
Carotid artery longitudinal wall motion: Regulatory factors and implications for arterial healthAu, Jason S 11 1900 (has links)
The carotid artery wall moves longitudinally along the length of the vessel, although little is known about what causes this motion, or what health information it represents. The overarching purpose of this dissertation was to investigate the regulation of carotid artery longitudinal wall motion (CALM) in humans, as well as how CALM can be used to infer information about arterial health. Through observational and experimental designs, we tested evidence for a structural ventricular-vascular coupling effect, which postulates that systolic anterograde CALM is influenced by the forward blood shear rate while systolic retrograde CALM is influenced by left ventricular rotation, although the data suggests a moderate influence of left ventricular rotation, and minimal influence of shear rate. In cross-sectional analyses, we demonstrated that diastolic CALM variables are better related to age and health status compared to systolic CALM displacement and that this relationship was independent of traditional measures of arterial stiffness. These experimental and observational results directed the use of diastolic CALM as a potential indicator of arterial health in subsequent studies, due to the relative independence from systolic events. While there was no effect of 12-weeks of exercise training in healthy men on diastolic CALM variables, we observed increased systolic retrograde CALM and diastolic CALM acceleration in men with a history of resistance exercise training compared to sedentary men, suggesting an effect of habitual exercise training. Our novel findings suggest that CALM is regulated by a complex system, in part related to both arterial wall structure and ventricular-vascular coupling, and may have clinical value in complimenting measures of traditional arterial stiffness in humans. Future studies should examine whether local changes to arterial wall structure or indirect changes in regulatory control dictate differences in CALM with aging and with chronic exercise training, before integrating CALM into routine measurement of arterial health. / Thesis / Doctor of Philosophy (PhD) / We have known for a long time that arteries expand in order to absorb pressure; however, only recently have we identified that arteries also move longitudinally along the length of the arterial wall. The overarching purpose of this dissertation was to study what causes carotid artery longitudinal wall motion (CALM), and how we can use this information to understand arterial health. We demonstrated that CALM is partly controlled through the forward blood velocity wave and left ventricular rotation of the heart, and that diastolic CALM is uniquely related to aging and health status, but is not impacted by exercise training in healthy men. There are many aspects of CALM that need to be examined before wide-spread use, though our results indicate that CALM represents a new way of studying arterial health, which has the potential to complement traditional measures of cardiovascular disease risk in humans.
|
22 |
The Effects of Weight Gain and Atorvastatin Treatment on Arterial StiffnessOrr, Jeb Stuart 04 June 2009 (has links)
Aging is characterized by a progressive stiffening of large elastic arteries in the cardiothoracic region. Importantly, large artery stiffness is an independent predictor of cardiovascular events and mortality in both healthy and diseased populations. The results of several studies suggest that obesity, particularly visceral adiposity, is associated with the accelerated stiffening of central elastic arteries in middle-aged and older adults. Despite the widely recognized association between obesity, aging and arterial stiffness, there remains a paucity of information regarding both the initiation of arterial stiffening and effective treatment strategies. To address these issues, we tested the hypotheses that weight gain increases arterial stiffness in nonobese young males, and atorvastatin treatment reduces large artery stiffness in overweight and obese middle-aged and older adults. Consistent with our first hypothesis, weight gain increased arterial stiffness in nonobese young men. In addition, we demonstrated that, independent of total body fat, those individuals with relatively larger increases in abdominal visceral fat also experienced correspondingly larger increases in arterial stiffness. Regarding our second hypothesis, atorvastatin treatment decreased arterial stiffness in overweight and obese middle-aged and older adults. Importantly, the reduction in arterial stiffness with atorvastatin appeared to be independent of the reduction in C-reactive protein. The findings of the present studies could potentially lead to the identification of effective strategies for the prevention and treatment of arterial stiffening in the population. / Ph. D.
|
23 |
Physical activity, sedentary behavior, and cardiovascular health of adults with and without Down syndromeBallenger, Brantley Kyle 10 May 2024 (has links) (PDF)
Down syndrome (DS) is the most common genetic condition caused by an extra copy of chromosome 21. Adults with DS have cardiovascular and metabolic alteration, which may lead to an increased number of cardiovascular disease risk factors in this population. Such impairments may affect their ability to exercise and perform moderate-to-vigorous physical activity (MVPA). Moreover, MVPA may affect arterial health differently in adults with DS due to endothelial dysfunction and sympathetic impairment. The purpose of this dissertation was to investigate differences in cardiovascular health and physical activity (PA) profiles between adults with and without DS. Specific aims of this dissertation were to determine whether traditional cardiovascular disease risk factors predict arterial stiffness in adults with and without DS, investigate differences in PA and sedentary behavior (SB) levels and patterns using population-specific activity intensity cut-points in adults with and without DS, and to investigate whether DS moderates the relationship between SB and MVPA levels and arterial stiffness. Results from stepwise linear regression indicated that age, DS, and waist circumference significantly predicted arterial stiffness for the entire sample, and that many of the risk factors that predict arterial stiffness in adults without DS – body composition, blood pressure, and MVPA – do not predict arterial stiffness in adults with DS. Results from mixed-model ANOVA indicated that adults with DS had less sedentary time but greater MVPA than adults without DS and that adults with DS performed greater number of sedentary and MVPA bouts than adults without DS; however, these bouts were of shorter duration. Lastly, results from moderation analysis indicated that DS moderated the relationship between MVPA and arterial stiffness; however, the effect of age was greater than MVPA or DS on arterial stiffness. Adults with DS have greater number of cardiovascular disease risk factors than adults without DS; however, this does not appear to increase arterial stiffness. Furthermore, adults with DS may have better PA and SB profiles than adults without DS; however, MVPA levels do not affect arterial stiffness in this population. Therefore, differences in cardiovascular health and PA profiles may identify disparities in health between adults with and without DS.
|
24 |
Chronic obstructive pulmonary disease, pulmonary function and cardiovascular diseaseMcAllister, David Anthony January 2011 (has links)
Cardiovascular disease is common in Chronic Obstructive Pulmonary Disease (COPD), and forced expiratory volume in one second (FEV1) independently predicts cardiovascular morbidity and mortality. Pathological changes in the systemic vasculature have been proposed as potential mechanisms linking COPD to cardiovascular disease, and patients with COPD may be at increased risk of acute myocardial infarction during acute exacerbations. Notwithstanding causation, FEV1 may be a useful prognostic marker in patients undergoing cardiac surgery. This thesis examined these three aspects of cardiovascular co-morbidity in relation to COPD and FEV1. In 2,241 consecutive cardiac surgery patients, FEV1 was associated with length of hospital stay (p<0.001) and mortality (p<0.001) adjusting for age, sex, height, body mass index, socioeconomic status, smoking, cardiovascular risk factors, chronic pulmonary disease, and type/urgency of surgery. In a survey of Scottish Respiratory Consultants there was no consensus regarding the investigation and management of acute coronary syndrome in exacerbation of COPD. In a case-series of 242 patients with exacerbations 2.5% (95% CI 1.0 to 5.6%) had chest pain, raised serum troponin and serial electrocardiogram changes suggestive of acute coronary syndrome. However, over half reported chest pain, while raised troponin was not associated with chest pain or serial ECG changes. Carotid-radial pulse wave velocity (PWV), aortic distensibility, and aortic calcification were measured to assess the relationship of the systemic vasculature to FEV1 and emphysema severity on CT. In adjusted analyses, emphysema was associated with PWV in patients with COPD (p = 0.006) and, in population based samples, with extent of distal aortic calcification (p=0.02) but not with aortic distensibility (p=0.60). This thesis found that FEV1 was associated with mortality and length of hospital stay in patients undergoing cardiac surgery, and that chest pain and raised troponin were common but unrelated in exacerbation of COPD. In the vascular studies distal but not proximal vascular pathology was associated with FEV1, and if COPD is truly related to systemic arterial disease, the distal arterial tree is implicated.
|
25 |
Imaging and modeling the cardiovascular systemMaksuti, Elira January 2016 (has links)
Understanding cardiac pumping function is crucial to guiding diagnosis, predicting outcomes of interventions, and designing medical devices that interact with the cardiovascular system. Computer simulations of hemodynamics can show how the complex cardiovascular system is influenced by changes in single or multiple parameters and can be used to test clinical hypotheses. In addition, methods for the quantification of important markers such as elevated arterial stiffness would help reduce the morbidity and mortality related to cardiovascular disease. The general aim of this thesis work was to improve understanding of cardiovascular physiology and develop new methods for assisting clinicians during diagnosis and follow-up of treatment in cardiovascular disease. Both computer simulations and medical imaging were used to reach this goal. In the first study, a cardiac model based on piston-like motions of the atrioventricular plane was developed. In the second study, the presence of the anatomical basis needed to generate hydraulic forces during diastole was assessed in heathy volunteers. In the third study, a previously validated lumped-parameter model was used to quantify the contribution of arterial and cardiac changes to blood pressure during aging. In the fourth study, in-house software that measures arterial stiffness by ultrasound shear wave elastography (SWE) was developed and validated against mechanical testing. The studies showed that longitudinal movements of the atrioventricular plane can well explain cardiac pumping and that the macroscopic geometry of the heart enables the generation of hydraulic forces that aid ventricular filling. Additionally, simulations showed that structural changes in both the heart and the arterial system contribute to the progression of blood pressure with age. Finally, the SWE technique was validated to accurately measure stiffness in arterial phantoms. / <p>QC 20161115</p>
|
26 |
Acute, ambulatory and central blood pressure measurements in diabetesWijkman, Magnus January 2012 (has links)
Background: In patients with diabetes, high blood pressure is an established risk factor for cardiovascular disease. The aim of this thesis was to explore the associations between blood pressure levels measured with different techniques and during different circumstances, and the degree of cardiovascular organ damage and subsequent prognosis in patients with diabetes. Methods: We analysed baseline data from patients with type 2 diabetes who participated in the observational cohort study CARDIPP (Cardiovascular Risk factors in Patients with Diabetes – a Prospective study in Primary care), and longitudinal data from patients registered in the Swedish national quality registry RIKS-HIA (Register of Information and Knowledge about Swedish Heart Intensive care Admissions). Patients in CARDIPP underwent nurse-recorded, 24-hour ambulatory and non-invasive central blood pressure measurements. Patients in RIKS-HIA had their systolic blood pressure measured upon hospitalisation for acute chest pain. Results: In CARDIPP, nearly one in three patients with office normotension (<130/80 mmHg) were hypertensive during the night (≥120/70 mmHg). This phenomenon, masked nocturnal hypertension, was significantly associated with increased arterial stiffness and increased central blood pressure. Furthermore, nearly one in five CARDIPP patients with office normotension had high central pulse pressure (≥50 mmHg), and there was a significant association between high central pulse pressure and increased carotid intima-media thickness and increased arterial stiffness. Among CARDIPP patients who used at least one antihypertensive drug, those who used beta blockers had significantly higher central pulse pressure than those who used other antihypertensive drugs, but there were no significant between-group differences concerning office or ambulatory pulse pressures. In CARDIPP patients with or without antihypertensive treatment, ambulatory systolic blood pressure levels were significantly associated with left ventricular mass, independently of central systolic blood pressure levels. When RIKS-HIA patients, admitted to hospital for chest pain, were stratified in quartiles according to admission systolic blood pressure levels, the risk for all-cause one-year mortality was significantly lower in patients with admission systolic blood pressure in the highest quartile (≥163 mmHg) than in patients with admission systolic blood pressure in the reference quartile (128-144 mmHg). This finding remained unaltered when the analysis was restricted to include only patients with previously known diabetes. Conclusions: In patients with type 2 diabetes, ambulatory or central blood pressure measurements identified patients with residual risk factors despite excellent office blood pressure control or despite ongoing antihypertensive treatment. Ambulatory systolic blood pressure predicted left ventricular mass independently of central systolic blood pressure. In patients with previously known diabetes who were hospitalised for acute chest pain, there was an inverse relationship between systolic blood pressure measured at admission and the risk for one-year all-cause mortality.
|
27 |
Impacto de marcadores genéticos no fenótipo de rigidez arterial em uma população geral / Impact of genetic markers on arterial stiffness phenotype in a general populationAlvim, Rafael de Oliveira 07 August 2012 (has links)
Introdução: A rigidez arterial é um fenômeno complexo caracterizado pela diminuição da complacência vascular frente aos estímulos fisiológicos e patológicos. Semelhantemente a outros fenótipos cardiovasculares, a etiologia da rigidez arterial é modulada por fatores ambientais e genéticos. Levando em consideração a moderada herdabilidade e a característica poligênica do presente fenótipo, torna-se interessante a investigação de marcadores genéticos referentes aos diferentes sistemas envolvidos no remodelamento vascular. Objetivo: Avaliar o impacto dos polimorfismos C242T da subunidade p22phox da NADPH oxidase, G1036C da TXNIP, C609T/T471C da APOE, G1355A da elastina, I/D da ECA e A855G da MMP-9 no fenótipo de rigidez arterial em uma população geral. Métodos: Participaram do estudo 1.663 indivíduos da população geral da cidade de Vitória-ES. O DNA foi extraído a partir de uma amostra de sangue venoso. Posteriormente foram realizadas as genotipagens para as variantes genéticas supracitadas. A rigidez arterial foi avaliada por meio do método da velocidade de onda de pulso (VOP). Resultados: Em relação à VOP, os polimorfismos C242T da subunidade p22phox da NADPH oxidase e G1036C da TXNIP foram signifcativamente associados. Os indivíduos portadores do genótipo TT do polimorfismo C242T da subunidade p22phox (CC+TC=9,8 m/s versus TT=10,1 m/s, p=0,02) e do alelo G do polimorfismo G1036C da TXNIP (CC=9,8 m/s versus CG+GG=10,0 m/s, p=0,03) apresentaram maiores valores da VOP. Entretanto os polimorfismos C609T/T471C da APOE (2=10,0 m/s, 3=9,8 m/s, 4=9,8 m/s, p=0,60), G1355A da elastina (AA=9,8 m/s, GA=9,9 m/s, GG=9,8 m/s, p=0,92), I/D da ECA (DD=9,8 m/s, DI=9,8 m/s, II=9,9 m/s, p=0,53) e A855G da MMP-9 (AA=9,8 m/s, GA=9,8 m/s, GG= 9,8 m/s, p=0,60) não demonstraram tal associação. Somente o genótipo TT do polimorfismo C242T da subunidade p22phox (OR=1,93, p=0,002) apresentou um risco significativamente aumentado para o fenótipo de rigidez arterial. Já os polimorfismos G1036C da TXNIP (OR=1,19, p=0,19), C609T/T471C da APOE (OR=1,14, p=0,33), G1355A da elastina (OR=0,81, p=0,28), I/D da ECA (OR=0,91, p=0,48) e A855G da MMP-9 (OR=1,01, p=0,95) não apresentaram risco. Conclusão: Os polimorfismos C242T da subunidade p22phox da NADPH oxidase e G1036C da TXNIP podem contribuir como moduladores genéticos no enrijecimento vascular / Introduction: Arterial stiffness is a complex phenomenon characterized by decreased vascular compliance during physiological and pathological stimuli. Similar to other cardiovascular phenotypes, arterial stiffness etiology is modulated by environmental and genetic factors. Considering the moderate heritability and its polygenic phenotype, genetic markers investigations related to different systems involved in vascular remodeling are interesting. Objectives: To assess the impact of the p22phox C242T, TXNIP G1036C, APOE C609T/T471C, elastin G1355A, ACE I/D and MMP-9 A855G polymorphisms on arterial stiffness phenotype in a general population. Methods: This study included 1,663 individuals of the general population from Vitória-ES. DNA was extracted from a venous blood sample and genotyping assays were performed for the genetic variants described above. Arterial stiffness was evaluated by pulse wave velocity (PWV). Results: Regarding PWV, p22phox C242T and TXNIP G1036C polymorphisms were significantly associated. Individuals carrying TT genotype of the p22phox C242T (CC + CT vs TT = 9.8 m/s = 10.1 m/s, p = 0.02) and individuals carrying G allele of the TXNIP G1036C polymorphisms (CG + CC = 9.8 m/s vs GG = 10.0 m/s, p = 0.03) had higher PWV values. However, APOE C609T/T471C (2=10.0 m/s, 3=9.8 m/s, 4=9.8 m/s, p=0.60), elastin G1355A (AA=9.8 m/s, GA=9.9 m/s, GG=9.8 m/s, p=0.92), ACE I/D (DD=9.8 m/s, DI=9.8 m/s, II=9.9 m/s, p=0.53) and MMP-9 A855G (AA=9.8 m/s, GA=9.8 m/s, GG= 9.8 m/s, p=0.60) polymorphisms did not present association. Only the TT genotype of the p22phox C242T polymorphism (OR = 1.93, p = 0.002) presented an increased risk for the arterial stiffness phenotype. Already TXNIP G1036C (OR=1.19, p=0.19), APOE C609T/T471C (OR=1.14, p=0.33), elastin G1355A (OR=0.81, p=0.28), ACE I/D (OR=0.91, p=0.48) and MMP-9 A855G (OR=1.01, p=0.95) polymorphisms did not present risk. Conclusion: The p22phox C242T and the TXNIP G1036C polymorphisms may contribute to genetic modulators in vascular stiffening
|
28 |
Chronic passive heat therapy as a novel means of improving vascular function in sedentary humansBrunt, Vienna 27 October 2016 (has links)
Cardiovascular disease is the leading cause of death in the developed world. The majority of cardiovascular diseases are characterized by disorders of the arteries, predominantly caused by endothelial dysfunction and arterial stiffening. Passive heat stress results in elevations in core temperature (inducing heat shock protein expression) and changes in cardiovascular hemodynamics, such as increased cardiac output and shear stress, that are similar to exercise. Thus, repeated passive heat stress (“heat therapy”) may provide an alternative means of improving cardiovascular health, particularly for patients with limited exercise tolerance and/or capabilities. Therefore, the goal of this dissertation was to perform integrative studies to determine the effects of heat therapy on vascular function and the associated cellular pathways in young, sedentary humans.
Twenty subjects were assigned to participate in 8 weeks (4-5x/week) of heat therapy (N=10; immersion in a 40.5°C bath sufficient to maintain rectal temperature ≥38.5°C for 60 min/session) or thermoneutral water immersion (N=10; sham).
As discussed in Chapter V, we found that heat therapy improved numerous well-established biomarkers of conduit vessel/macrovascular function, including flow-mediated dilation (a measure of endothelial function), arterial stiffness, intima media thickness, and blood pressure. Heat therapy also improved microvascular function, as discussed in Chapter VI, measured as improved cutaneous thermal hyperemia and nitric oxide-dependent dilation (the difference between microdialysis sites receiving Lactated Ringer’s [control] and nitric oxide synthase inhibition). No changes were observed in any variables in sham subjects. In Chapter VII, we showed that both direct cellular heating and serum collected from human subjects following heat therapy improved nitric oxide bioavailability and angiogenesis in cultured endothelial cells, providing potential mechanisms by which heat therapy improves vascular function in vivo.
Therefore, the studies described herein provide comprehensive evidence that passive heat therapy improves vascular health and insight into the mechanisms involved. Our data presented in Chapters IV-VII, combined with pilot data we conducted in spinal cord injured individuals (Chapter VIII), strongly indicate that passive heat therapy could be used as a simple and effective tool to improve cardiovascular health in a variety of patient populations.
This dissertation includes published and unpublished co-authored material.
|
29 |
Elaboration et évaluation d’un programme d’exercice aérobie sur cycloergomètre et de sa récupération immergée chez le patient atteint de polyarthrite rhumatoïde. / Development and evaluation of an aerobic exercise program on ergometer bicycle and partial body immersion recovery in patients with rheumatoid arthritis.Peres, Daniele 07 December 2018 (has links)
La polyarthrite rhumatoïde (PR) est une maladie inflammatoire, auto-immune, chronique et systémique avec la présence d’arthrites et synovites périphériques. Une autre conséquence sévère de la maladie et de ses traitements est la présence d’une rigidité artérielle élevée précoce, par conséquent une haute incidence de problèmes cardiovasculaires pour les sujets atteints. La pratique d'exercices physiques (EP) est reconnue comme une des thérapies non-pharmacologiques les plus efficaces pour lutter contre le risque cardiovasculaire. Cependant la population PR présente un bas niveau de pratique d’activité physique et les programmes d’EP sont rarement proposés dans la prise en charge thérapeutique de ces patients. Pour dépasser cette problématique l’association de la cryothérapie à un programme d’EP adapté semble être une stratégie intéressante. L’objectif de ce travail était de concevoir et de tester un programme d’EP associé à de la cryothérapie adapté aux patients PR afin de lutter contre le risque cardiovasculaire.A partir d’une revue systématique, nous avons montré le caractère lacunaire de la littérature en termes de programme d’EP associé à de la cryothérapie pour des patients PR, le manque de consensus sur les méthodes utilisées aussi bien pour le type d’EP à proposer que pour les méthodes de cryothérapie et les températures employées. Face à cette situation, nous avons proposé plusieurs études préliminaires afin de déterminer les modalités d’exercice et de cryothérapie les plus appropriées pour définir un programme simple, efficace et adapté aux patients PR. Ces travaux ont été réalisés d’une part avec des sujets sains et d’autre part avec des patients PR. Nous avons également entrepris de mieux définir les conditions d’utilisation de la vitesse de propagation de l’onde de pression pour traduire la rigidité artérielle, afin d’utiliser cette dernière comme un marqueur des effets de nos propositions de programme d’EP sur le risque cardiovasculaire. Enfin nous avons tenté d’évaluer quels pouvaient être les freins à la pratique d’EP pour ces patients afin de pouvoir les prendre en compte et les contourner dans la mise en place de nos propositions. Les principaux résultats de nos travaux nous ont permis de définir les caractéristiques d’un programme d’EP associé à de la cryothérapie pour des patients PR afin d’agir sur leur rigidité artérielle.Ce programme, intitulé Prexcrim, a été mise en œuvre avec un groupe de patients atteints de PR. Les premiers résultats que nous avons obtenus confirment la faisabilité de nos propositions et la bonne tolérance des patients. Aucune sortie de l’étude ou effet secondaire a été observé. A ce stade des inclusions et de l’analyse des résultats, il semble que le programme d’EP proposé permette de modifier la rigidité artérielle en particulier des patients qui présentaient une rigidité artérielle élevée au départ. Il n’a pas été observé d’aggravation de la maladie ou du syndrome inflammatoire ce qui semble renforcer l’intérêt de la méthode de cryothérapie proposée. Les inclusions qui se poursuivent permettront sans doute d’affiner ces premières interprétations.En conclusion, notre travail a permis de combler une partie des lacunes constatées dans la littérature en termes de lutte contre le risque cardiovasculaires accru constaté chez les patients PR. Notre approche a permis la réalisation d’un programme simple et facile d’EP associé à de la cryothérapie, dont les premiers résultats répondent aux attentes fixées. Les premières analyses que nous avons réalisées montrent que les principes d’individualisation et de progressivité seront certainement à améliorer pour optimiser les effets du programme. / Rheumatoid arthritis (RA) is an inflammatory, autoimmune, chronic and systemic disease with the presence of arthritis and peripheral synovitis. Another severe consequence of the disease and its treatments is the presence of early high arterial stiffness, hence a high incidence of cardiovascular problems for the subjects with RA. The practice of physical exercises (PE) is recognized as one of the most effective non-pharmacological therapies against the cardiovascular risk. However, the RA population has a low level of physical activity and PE programs are rarely offered in the therapeutic management of these patients. To overcome this problem, the association of cryotherapy to an appropriate PE program seems to be an interesting strategy. The objective of this work was to design and test a PE program associated with cryotherapy adapted to patients with RA in order to fight against the cardiovascular risk.From a systematic review, we have shown the lack of the literature in terms of PE program associated with cryotherapy for patients with RA, the lack of consensus on the methods used for both the type of PE to be proposed and the cryotherapy methods and temperatures employed. Consequently, we have proposed several preliminary studies to determine the most appropriate exercise and cryotherapy modalities for defining a simple, effective and suitable program. These works were carried out firstly in healthy subjects and after in patients with RA. We have also undertaken to better define the used conditions of the pulse wave velocity to interpret arterial stiffness and use it as a marker of effects of our PE program on cardiovascular risk. Finally, we tried to evaluate what could be the obstacles to the practice of PE for these patients, to consider and overcome them in the implementation of our proposals. The main results of our works allowed us to define the characteristics of a PE program associated with cryotherapy for patients with RA to act on their arterial stiffness.This program, entitled Prexcrim, was implemented with a group of patients with RA. The first results confirmed the feasibility of our proposals and the good tolerance of patients. No study output or side effect was observed in the patients. At this stage of inclusion and analysis of the results, it appears that the proposed PE program allows for changes in arterial stiffness, particularly for patients with high arterial stiffness. It was not observed exacerbation of the disease or inflammatory syndrome, which seems to reinforce the interest of the proposed cryotherapy method. The inclusions that continue will undoubtedly refine these first interpretations.In conclusion, our work proposes some responses about the lack in terms of the fight against the increased cardiovascular risk observed in patients with RA. Our approach allowed the realization of a simple and easy PE program associated with cryotherapy. The first results meet our expectations. The first analyzes shown that the principles of individualization and progressivity need to be improved to optimize the effects of the program.
|
30 |
Modulation of arterial stiffness by angiotensin receptors and nitric oxide in the insulin resistance syndromeBrillante, Divina Graciela, Clinical School - St George Hospital, Faculty of Medicine, UNSW January 2008 (has links)
The insulin resistance syndrome [INSR] is associated with increased cardiovascular risk and affects up to 25% of the Australian population. The mechanism underlying the relationship between the INSR and increased cardiovascular risk is controversial. We postulated that perturbations in the renin-angiotensin system [RAS] and endothelium-derived NO may be implicated in the development of early vascular changes in the INSR. Repeated measurements of arterial stiffness [using digital photoplethysmography] and haemodynamic parameters in response to vasoactive medications were used to demonstrate the functional expression of angiotensin II [Ang II] receptors and NO synthase [NOS]. Ang II acts via two main receptor sub-types: the Ang II type 1 [AT1] and Ang II type 2 [AT2] receptors. The AT1 receptor is central to the development of arterial stiffness and endothelial dysfunction. The role of AT2 receptors in humans is controversial but is postulated to counter-act AT1 receptor mediated effects in diseased vascular beds. We demonstrated increased AT1 and AT2 receptor-mediated effects in small to medium-sized arteries of subjects with early INSR [Chapter 6]. In addition, functional expression of AT2 receptors in adult insulin resistant humans [Chapter 5], but not in healthy volunteers [Chapter 4] was demonstrated. AT1 receptor blockade in subjects with early INSR resulted in improvements in vascular function, with a consequent functional down-regulation of AT2 receptors [Chapter 7]. Functional NOS expression was demonstrated to be increased in subjects with early INSR compared with healthy controls [Chapter 6]. This was postulated to be a homeostatic response to counteract early vascular changes in subjects with early INSR. AT1 receptor blockade in these subjects reduced functional NOS expression [Chapter 8]. In conclusion, patients with early INSR represent a model of early disease where early intervention may be able to reverse the process incited by the initial exposure to multiple cardiovascular risk factors. Early vascular changes in these individuals are mediated at least in part, by increased AT1 receptor activity and/or expression, and may be detected by changes in arterial stiffness indices and non-invasive vascular reactivity studies. There is a compensatory increase in AT2 receptor and NOS expression/activity to counter-act these vascular changes.
|
Page generated in 0.0697 seconds